{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:57:46Z","timestamp":1769389066240,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,5]]},"DOI":"10.7759\/cureus.91659","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T11:56:41Z","timestamp":1757073401000},"source":"Crossref","is-referenced-by-count":1,"title":["The Effects of Hypertension Treatment on Heart Rate Variability: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Dylan","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Bonifanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Lound","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey N","family":"Mayrovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Biochemistry, Anaerobic Glycolysis","author":"Melkonian EA","year":"2025","unstructured":"Melkonian EA, Schury MP. Biochemistry, Anaerobic Glycolysis. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref2","article-title":"Mortality in the United States, 2021","volume":"4","author":"Xu J","year":"2022","unstructured":"Xu J, Murphy SL, Kochanek KD, Arias E. Mortality in the United States, 2021. NCHS Data Brief. 2022, 4:1-8.","journal-title":"NCHS Data Brief"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills KT","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020, 16:223-37. 10.1038\/s41581-019-0244-2","journal-title":"Nat Rev Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills KT","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, et al.. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016, 134:441-50. 10.1161\/CIRCULATIONAHA.115.018912","journal-title":"Circulation"},{"key":"ref5","article-title":"Essential Hypertension","author":"Iqbal AM","year":"2023","unstructured":"Iqbal AM, Jamal SF. Essential Hypertension. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams B","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al.. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018, 39:3021-104. 10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/5586403","article-title":"Comparative analysis of hypertension guidelines: unveiling consensus and discrepancies in lifestyle modifications for blood pressure control","volume":"2023","author":"Wang Y","year":"2023","unstructured":"Wang Y, Liu Y, Liu L, Hong L, Chen H. Comparative analysis of hypertension guidelines: unveiling consensus and discrepancies in lifestyle modifications for blood pressure control. Cardiol Res Pract. 2023, 2023:5586403. 10.1155\/2023\/5586403","journal-title":"Cardiol Res Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/s23042152","article-title":"Heart rate variability analysis on electrocardiograms, seismocardiograms and gyrocardiograms of healthy volunteers and patients with valvular heart diseases","volume":"23","author":"Sieci\u0144ski S","year":"2023","unstructured":"Sieci\u0144ski S, Tkacz EJ, Kostka PS. Heart rate variability analysis on electrocardiograms, seismocardiograms and gyrocardiograms of healthy volunteers and patients with valvular heart diseases. Sensors (Basel). 2023, 23:10.3390\/s23042152","journal-title":"Sensors (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s40101-019-0193-2","article-title":"Pitfalls of assessment of autonomic function by heart rate variability","volume":"38","author":"Hayano J","year":"2019","unstructured":"Hayano J, Yuda E. Pitfalls of assessment of autonomic function by heart rate variability. J Physiol Anthropol. 2019, 38:3. 10.1186\/s40101-019-0193-2","journal-title":"J Physiol Anthropol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-9877(96)90029-8","article-title":"Central origin of decreased heart rate variability in patients with cardiovascular diseases","volume":"46","author":"Wolk R","year":"1996","unstructured":"Wolk R. Central origin of decreased heart rate variability in patients with cardiovascular diseases. Med Hypotheses. 1996, 46:479-81. 10.1016\/s0306-9877(96)90029-8","journal-title":"Med Hypotheses"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104907","article-title":"Heart rate variability in the prediction of mortality: a systematic review and meta-analysis of healthy and patient populations","volume":"143","author":"Jarczok MN","year":"2022","unstructured":"Jarczok MN, Weimer K, Braun C, Williams DP, Thayer JF, G\u00fcndel HO, Balint EM. Heart rate variability in the prediction of mortality: a systematic review and meta-analysis of healthy and patient populations. Neurosci Biobehav Rev. 2022, 143:104907. 10.1016\/j.neubiorev.2022.104907","journal-title":"Neurosci Biobehav Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.94.11.2850","article-title":"Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study","volume":"94","author":"Tsuji H","year":"1996","unstructured":"Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, Levy D. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 1996, 94:2850-5. 10.1161\/01.cir.94.11.2850","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(94)90059-0","article-title":"Heart rate variability: a measure of cardiac autonomic tone","volume":"127","author":"Stein P","year":"1994","unstructured":"Stein P, Bosner M, Kleiger R, Conger B. Heart rate variability: a measure of cardiac autonomic tone. Am Heart J. 1994, 127:1376-81. 10.1016\/0002-8703(94)90059-0","journal-title":"Am Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a014868","article-title":"Heart rate variability: standards of measurement, physiological interpretation, and clinical use","volume":"17","author":"Malik M","year":"1996","unstructured":"Malik M, Bigger JT, Camm AJ, et al.. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996, 17:354-81. 10.1093\/oxfordjournals.eurheartj.a014868","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1470684","article-title":"Analysis of frequency-domain heart rate variability using absolute versus normalized values: implications and practical concerns","volume":"15","author":"Amekran Y","year":"2024","unstructured":"Amekran Y, Damoun N, El Hangouche AJ. Analysis of frequency-domain heart rate variability using absolute versus normalized values: implications and practical concerns. Front Physiol. 2024, 15:1470684. 10.3389\/fphys.2024.1470684","journal-title":"Front Physiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/30.7.913","article-title":"Interpretation of normalized spectral heart rate variability indices in sleep research: a critical review","volume":"30","author":"Burr RL","year":"2007","unstructured":"Burr RL. Interpretation of normalized spectral heart rate variability indices in sleep research: a critical review. Sleep. 2007, 30:913-9. 10.1093\/sleep\/30.7.913","journal-title":"Sleep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2016.02.006","article-title":"Reference values for time- and frequency-domain heart rate variability measures","volume":"13","author":"Sammito S","year":"2016","unstructured":"Sammito S, B\u00f6ckelmann I. Reference values for time- and frequency-domain heart rate variability measures. Heart Rhythm. 2016, 13:1309-16. 10.1016\/j.hrthm.2016.02.006","journal-title":"Heart Rhythm"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2017.00258","article-title":"An overview of heart rate variability metrics and norms","volume":"5","author":"Shaffer F","year":"2017","unstructured":"Shaffer F, Ginsberg JP.  An overview of heart rate variability metrics and norms. Front Public Health. 2017, 5:258. 10.3389\/fpubh.2017.00258","journal-title":"Front Public Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X16999201231203854","article-title":"Analysis of heart rate variability and implication of different factors on heart rate variability","volume":"17","author":"Tiwari R","year":"2021","unstructured":"Tiwari R, Kumar R, Malik S, Raj T, Kumar P. Analysis of heart rate variability and implication of different factors on heart rate variability. Curr Cardiol Rev. 2021, 17:e160721189770. 10.2174\/1573403X16999201231203854","journal-title":"Curr Cardiol Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2018_292","article-title":"Influence of heart rate, age, and gender on heart rate variability in adolescents and young adults","volume":"1133","author":"Est\u00e9vez-B\u00e1ez M","year":"2019","unstructured":"Est\u00e9vez-B\u00e1ez M, Carricarte-Naranjo C, Jas-Garc\u00eda JD, et al.. Influence of heart rate, age, and gender on heart rate variability in adolescents and young adults. Adv Exp Med Biol. 2019, 1133:19-33. 10.1007\/5584_2018_292","journal-title":"Adv Exp Med Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco AC","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al.. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018, 169:467-73. 10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1159\/000177128","article-title":"Evaluation of the sympathetic nervous system using heart rate variability and plasma hormones in hypertensive patients treated with cilazapril and atenolol","volume":"87","author":"Campelo M","year":"1996","unstructured":"Campelo M, Pol\u00f3nia J, Serr\u00e3o P, Cerqueira-Gomes M. Evaluation of the sympathetic nervous system using heart rate variability and plasma hormones in hypertensive patients treated with cilazapril and atenolol. Cardiology. 1996, 87:402-8. 10.1159\/000177128","journal-title":"Cardiology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(98)00021-1","article-title":"Vagal cardiac activity in essential hypertension: the effects of metoprolol and ramipril","volume":"11","author":"Vesalainen RK","year":"1998","unstructured":"Vesalainen RK, Kantola IM, Airaksinen KEJ, Tahvanainen KUO, Kaila TJ. Vagal cardiac activity in essential hypertension: the effects of metoprolol and ramipril. Am J Hypertens. 1998, 11:649-58. 10.1016\/S0895-7061(98)00021-1","journal-title":"Am J Hypertens"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.2165\/00044011-200424110-00004","article-title":"Heart rate variability and baroreflex sensitivity during fosinopril, irbesartan and atenolol therapy in hypertension","volume":"24","author":"Rabbia F","year":"2004","unstructured":"Rabbia F, Silke B, Carra R, et al.. Heart rate variability and baroreflex sensitivity during fosinopril, irbesartan and atenolol therapy in hypertension. Clin Drug Investig. 2004, 24:651-9.","journal-title":"Clin Drug Investig"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000199225.17928.f5","article-title":"Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension","volume":"47","author":"Chern CM","year":"2006","unstructured":"Chern CM, Hsu HY, Hu HH, Chen YY, Hsu LC, Chao AC. Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension. J Cardiovasc Pharmacol. 2006, 47:169-74. 10.1097\/01.fjc.0000199225.17928.f5","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref26","article-title":"Comparative effect of bisoprolol and losartan in the treatment of essential hypertension","volume":"17","author":"Kekovi\u0107 G","year":"2012","unstructured":"Kekovi\u0107 G, Milovanovi\u0107 B, Davidovi\u0107 D, Rakovi\u0107 D, \u0106uli\u0107 M. Comparative effect of bisoprolol and losartan in the treatment of essential hypertension. J Res Med Sci. 2012, 17:1027-32.","journal-title":"J Res Med Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/08037051.2013.836810","article-title":"Heart rate variability on antihypertensive drugs in black patients living in sub-Saharan Africa","volume":"23","author":"Osakwe CE","year":"2014","unstructured":"Osakwe CE, Jacobs L, Anisiuba BC, et al.. Heart rate variability on antihypertensive drugs in black patients living in sub-Saharan Africa. Blood Press. 2014, 23:174-80. 10.3109\/08037051.2013.836810","journal-title":"Blood Press"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000523172.36857.53","article-title":"Age-dependent sympathetic neural responses to beta-1 selective betablockade in untreated hypertension related tachycardia","volume":"35","author":"Hering D","year":"2017","unstructured":"Hering D, Kucharska W, Czechowicz K, Chrostowska M, Narkiewicz K. Age-dependent sympathetic neural responses to beta-1 selective betablockade in untreated hypertension related tachycardia. J Hypertens. 2017, 35:76. 10.1097\/01.hjh.0000523172.36857.53","journal-title":"J Hypertens"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072102","article-title":"A randomized controlled study on the effects of bisoprolol and atenolol on sympathetic nervous activity and central aortic pressure in patients with essential hypertension","volume":"8","author":"Zhou WJ","year":"2013","unstructured":"Zhou WJ, Wang RY, Li Y, Chen DR, Chen EZ, Zhu DL, Gao PJ. A randomized controlled study on the effects of bisoprolol and atenolol on sympathetic nervous activity and central aortic pressure in patients with essential hypertension. PLoS One. 2013, 8:e72102. 10.1371\/journal.pone.0072102","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199917040-00009","article-title":"Effect of losartan on heart rate and blood pressure variability during tilt test and trinitroglycerine vasodilation","volume":"17","author":"Pancera P","year":"1999","unstructured":"Pancera P, Presciuttini B, Sansone S, Montagna L, Paluani F, Covi G, Lechi A. Effect of losartan on heart rate and blood pressure variability during tilt test and trinitroglycerine vasodilation. J Hypertens. 1999, 17:513-21. 10.1097\/00004872-199917040-00009","journal-title":"J Hypertens"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199917020-00005","article-title":"Assessment of heart rate variability after calcium antagonist and \u03b2-blocker therapy in patients with essential hypertension","volume":"17","author":"Rabbia F","year":"1999","unstructured":"Rabbia F, Martini G, Sibona MP, Grosso T, Simondi F, Chiandussi L, Veglio F. Assessment of heart rate variability after calcium antagonist and \u03b2-blocker therapy in patients with essential hypertension. Clin Drug Invest. 1999, 17:111-8. 10.2165\/00044011-199917020-00005","journal-title":"Clin Drug Invest"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199917050-00016","article-title":"Comparison of verapamil versus felodipine on heart rate variability in hypertensive patients","volume":"17","author":"Petretta M","year":"1999","unstructured":"Petretta M, Canonico V, Madrid A, et al.. Comparison of verapamil versus felodipine on heart rate variability in hypertensive patients. J Hypertens. 1999, 17:707-13. 10.1097\/00004872-199917050-00016","journal-title":"J Hypertens"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-7061(01)02218-x","article-title":"The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study","volume":"14","author":"Lefrandt JD","year":"2001","unstructured":"Lefrandt JD, Heitmann J, Sevre K, et al.. The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study. Am J Hypertens. 2001, 14:1083-9. 10.1016\/s0895-7061(01)02218-x","journal-title":"Am J Hypertens"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200102000-00015","article-title":"Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension","volume":"19","author":"Pellizzer AM","year":"2001","unstructured":"Pellizzer AM, Kamen PW, Esler MD, Lim S, Krum H. Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension. J Hypertens. 2001, 19:279-85. 10.1097\/00004872-200102000-00015","journal-title":"J Hypertens"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/00126097-200006000-00007","article-title":"Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension","volume":"5","author":"Kawano Y","year":"2000","unstructured":"Kawano Y, Makino Y, Okuda N, Takishita S, Omae T. Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension. Blood Press Monit. 2000, 5:181-5. 10.1097\/00126097-200006000-00007","journal-title":"Blood Press Monit"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2004.03.040","article-title":"Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction","volume":"101","author":"Zali\u016bnas R","year":"2005","unstructured":"Zali\u016bnas R, Brazdzionyte J, Zabiela V, Jurkevicius R. Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction. Int J Cardiol. 2005, 101:347-53. 10.1016\/j.ijcard.2004.03.040","journal-title":"Int J Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2003.02056.x","article-title":"Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension","volume":"57","author":"Minami J","year":"2004","unstructured":"Minami J, Numabe A, Andoh N, Kobayashi N, Horinaka S, Ishimitsu T, Matsuoka H. Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension. Br J Clin Pharmacol. 2004, 57:632-9. 10.1111\/j.1365-2125.2003.02056.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000170389.69202.53","article-title":"Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients","volume":"23","author":"Karas M","year":"2005","unstructured":"Karas M, Lacourci\u00e8re Y, LeBlanc AR, et al.. Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients. J Hypertens. 2005, 23:1251-60. 10.1097\/01.hjh.0000170389.69202.53","journal-title":"J Hypertens"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2021.4.07","article-title":"Effect of diltiazem on exercise tolerance in patients with stable coronary artery disease and hypertension","volume":"72","author":"Peng X","year":"2021","unstructured":"Peng X, Peng DF, Tang SY. Effect of diltiazem on exercise tolerance in patients with stable coronary artery disease and hypertension. J Physiol Pharmacol. 2021, 72:5-7. 10.26402\/jpp.2021.4.07","journal-title":"J Physiol Pharmacol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199705000-00017","article-title":"Evidence of increased sympathetic vasomotor drive with shorter acting dihydropyridine calcium channel antagonists in human hypertension: a study using spectral analysis of RR interval and systolic arterial pressure variability","volume":"29","author":"Lucini D","year":"1997","unstructured":"Lucini D, Mela GS, Malliani A, Pagani M. Evidence of increased sympathetic vasomotor drive with shorter acting dihydropyridine calcium channel antagonists in human hypertension: a study using spectral analysis of RR interval and systolic arterial pressure variability. J Cardiovasc Pharmacol. 1997, 29:676-83. 10.1097\/00005344-199705000-00017","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(00)01258-9","article-title":"Effects of amlodipine on baroreflex and sympathetic nervous system activity in mild-to-moderate hypertension","volume":"14","author":"Sich\u00e9 J","year":"2001","unstructured":"Sich\u00e9 J, Baguet J, Fagret D, Tr\u00e9mel F, de Gaudemaris R, Mallion J. Effects of amlodipine on baroreflex and sympathetic nervous system activity in mild-to-moderate hypertension. Am J Hypertens. 2001, 14:424-8. 10.1016\/S0895-7061(00)01258-9","journal-title":"Am J Hypertens"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2005.00464.x","article-title":"Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension","volume":"59","author":"Bilge AK","year":"2005","unstructured":"Bilge AK, Atilgan D, T\u00fckek T, Ozcan M, Ozben B, Koylan N, Meri\u00e7 M. Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension. Int J Clin Pract. 2005, 59:306-10. 10.1111\/j.1742-1241.2005.00464.x","journal-title":"Int J Clin Pract"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8563135","article-title":"Heart rate variability in patients with hypertension: the effect of metabolic syndrome and antihypertensive treatment","volume":"2020","author":"Maciorowska M","year":"2020","unstructured":"Maciorowska M, Krzesi\u0144ski P, Wierzbowski R, Gielerak G. Heart rate variability in patients with hypertension: the effect of metabolic syndrome and antihypertensive treatment. Cardiovasc Ther. 2020, 2020:8563135. 10.1155\/2020\/8563135","journal-title":"Cardiovasc Ther"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.31.443","article-title":"Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system","volume":"31","author":"Guzik P","year":"2008","unstructured":"Guzik P, Wykretowicz A, Krauze T, et al.. Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system. Hypertens Res. 2008, 31:443-53. 10.1291\/hypres.31.443","journal-title":"Hypertens Res"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1556\/APhysiol.98.2011.1.9","article-title":"Autonomic nervous system adjustment (ANSA) in patients with hypertension treated with enalapril","volume":"98","author":"Milovanovic B","year":"2011","unstructured":"Milovanovic B, Trifunovic D, Djuric D. Autonomic nervous system adjustment (ANSA) in patients with hypertension treated with enalapril. Acta Physiol Hung. 2011, 98:71-84. 10.1556\/APhysiol.98.2011.1.9","journal-title":"Acta Physiol Hung"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1996.tb00158.x","article-title":"Effects of acute and chronic angiotensin converting enzyme inhibition by spirapril on cardiovascular regulation in essential hypertensive patients. Assessment by spectral analysis and haemodynamic measurements","volume":"41","author":"Veerman DP","year":"1996","unstructured":"Veerman DP, Douma CE, Jacobs MC, Thien T, Van Montfrans GA. Effects of acute and chronic angiotensin converting enzyme inhibition by spirapril on cardiovascular regulation in essential hypertensive patients. Assessment by spectral analysis and haemodynamic measurements. Br J Clin Pharmacol. 1996, 41:49-56. 10.1111\/j.1365-2125.1996.tb00158.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2143\/AC.56.5.2005689","article-title":"Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients","volume":"56","author":"Guasti L","year":"2001","unstructured":"Guasti L, Petrozzino MR, Mainardi LT, et al.. Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients. Acta Cardiol. 2001, 56:289-95. 10.2143\/AC.56.5.2005689","journal-title":"Acta Cardiol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.174383","article-title":"Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study","volume":"58","author":"Zhang Y","year":"2011","unstructured":"Zhang Y, Agnoletti D, Safar ME, Blacher J. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study. Hypertension. 2011, 58:155-60. 10.1161\/HYPERTENSIONAHA.111.174383","journal-title":"Hypertension"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/404406-the-effects-of-hypertension-treatment-on-heart-rate-variability-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T11:56:42Z","timestamp":1757073402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/404406-the-effects-of-hypertension-treatment-on-heart-rate-variability-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.91659","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}